ALPRE Predilife S.A.

0.5496USD0.5000 EUR · EPA-4.21%Mkt Cap: 2.17M USDP/E: —

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. It provides breast cancer predictive assessment; and multi-pathology predictive assessment. The company also offers MammoRisk, …

Key Statistics

Company
Market Cap2.17M USD
Enterprise Value7.42M USD
Revenue (TTM)918.72K USD
Gross Profit901.08K USD
Net Income (TTM)-4.32M USD
Revenue/Share0.23 USD
Last Price0.5496 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees20
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0010169920
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.08
EV/Revenue8.08
P/S2.36
P/B-0.12
EPS (TTM)-0.92 USD
EPS (Forward)—
52W Range
0.49461% of range4.397
52W High4.397 USD
52W Low0.4946 USD
Profitability
Gross Margin98.08%
Oper. Margin-390.86%
EBITDA Margin0.00%
Profit Margin-470.74%
ROE56.91%
ROA-214.62%
ROIC—
ROCE—
Growth
Revenue Growth32.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.82M USD
CapEx (TTM)2.23K USD
FCF Margin-154.97%
FCF Yield-65.63%
Net Debt5.25M USD
Net Debt/EBITDA-1.47
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.80
Current Ratio0.56
Quick Ratio0.55
Book Value/Sh-4.56 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.95M
Float—
Insiders50.95%
Institutions0.00%
Technical
SMA 500.9611 (-42.8%)
SMA 2002.225 (-75.3%)
Beta0.24
S&P 52W Chg8.68%
Avg Vol (30d)620
Avg Vol (10d)565
Technical Indicators
RSI (14)28.1
MACD-0.1136
MACD Signal-0.0902
MACD Hist.-0.0234
BB Upper1.141 USD
BB Middle0.8260 USD
BB Lower0.5114 USD
BB Width76.19%
ATR (14)0.0544 USD
Vol Ratio (20d)0.72x

About Predilife (EPA: ALPRE)

›

Predilife (EPA: ALPRE) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 20 employees.

The shares were at 0.5000 EUR on 20 November 2026, down 84.1% over 52 weeks. Its 52-week range is 0.4500 EUR to 4.000 EUR: the price is 87.5% below the high and 11.1% above the low.

Its market capitalisation is 1.97M EUR.

Predilife reports return on equity of 56.9%, an operating margin of -390.9% and revenue up 32.1% year over year.

Its debt exceeds its cash by 4.78M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.